Efficacy and Safety of Non–Vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients With Impaired Liver Function: A Retrospective Cohort Study

BACKGROUND: Patients with impaired liver function (ILF) were excluded from clinical trials that investigated non–vitamin K antagonist oral anticoagulants (NOACs) for stroke prevention in patients with atrial fibrillation. The aim of this study was to evaluate the efficacy and safety of NOACs in atri...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:J Am Heart Assoc
Egile Nagusiak: Wang, Chun‐Li, Wu, Victor Chien‐Chia, Kuo, Chang‐Fu, Chu, Pao‐Hsien, Tseng, Hsiao‐Jung, Wen, Ming‐Shien, Chang, Shang‐Hung
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2018
Gaiak:
Original Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC6201449/
https://ncbi.nlm.nih.gov/pubmed/30371232
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/JAHA.118.009263
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak